Dr. Ning Liao: Benchmark in Precision Breast Surgical Oncology, Oncoplastic Reconstruction & Neoadjuvant Care at Guangdong Provincial People's Hospital

Professional Profile

Dr. Ning Liao is an internationally acclaimed breast surgical oncologist, Chief Physician, Doctoral Supervisor, and Director of the Breast Cancer Center at Guangdong Provincial People’s Hospital (GDPH). Widely recognized as a national standard-bearer in oncoplastic breast surgery, Dr. Liao bridges the highest rigor of oncological safety with advanced reconstructive techniques, empowering women to preserve both their physical health and personal wholeness.

Throughout her pioneering career, Dr. Liao has established standard-setting clinical pathways for breast cancer management across Southern China. Her practice is defined by a deep commitment to breast conservation, precision margin control, and the seamless integration of state-of-the-art neoadjuvant immunotherapies and targeted regimens that downstage locally advanced tumors, transforming previously inoperable cases into candidates for conservative surgery.

Key Clinical Specializations

• Precision Breast-Conserving Surgery (BCS): Pioneering sophisticated oncoplastic remodeling techniques that relocate glandular tissue to fill resection defects, maximizing cosmetic symmetry while guaranteeing microscopic margin-negative radicality.
• Immediate Oncoplastic Breast Reconstruction: Mastery of primary immediate reconstruction performed simultaneously with nipple-sparing or skin-sparing mastectomy. Dr. Liao is renowned for prepectoral implant reconstruction, acellular dermal matrix (ADM) integration, and autologous tissue flap transfers (DIEP/latissimus dorsi).
• Neoadjuvant Immunotherapy & Targeted Downstaging: Leading translational protocols in triple-negative breast cancer (TNBC) and HER2-positive breast cancer, combining immune checkpoint inhibitors and dual HER2 blockade to achieve remarkable pathological complete response (pCR) rates and enable conservative surgical salvage.
• Stereotactic Minimally Invasive Intervention for Microcalcifications: Utilizing digital mammography stereotactic guidance and vacuum-assisted biopsy (VABB) to achieve ultra-early diagnosis and complete percutaneous excision of suspicious clustered microcalcifications.

Academic Leadership & Landmark Research (2024–2025)

Dr. Ning Liao serves as a prominent investigator and key opinion leader in national and global breast cancer research. Her recent high-impact contributions have been highlighted in elite surgical and oncology journals, including Annals of Surgical Oncology and Breast Cancer Research and Treatment:

• Landmark Findings in Annals of Surgical Oncology: Leading prospective real-world multicenter investigations demonstrating the long-term oncological non-inferiority and superior quality-of-life outcomes of immediate breast reconstruction following neoadjuvant systemic therapy.
• Breakthroughs in Breast Cancer Research and Treatment: Unveiling real-world prospective cohort data evaluating the surgical safety, wound healing, and complication profiles in patients undergoing oncoplastic reconstruction following neoadjuvant immunotherapy regimens.
• Clinical Guidelines & National Consensus: Authoring core recommendations for Chinese consensus guidelines on breast-conserving surgery, oncoplastic reconstruction standards, and early breast cancer genetic testing (BRCA1/2).

International Patient Coordination & Fast-Track Access

China Medical Concierge – Shanghai (CMCS) provides dedicated health management and medical concierge services connecting patients across Greater China and overseas with top-tier clinical leaders. For patients seeking evaluation and personalized surgical planning with Dr. Ning Liao, CMCS coordinates end-to-end care:

• Rapid remote expert review of mammograms, breast MRI, and pathology biopsy specimens;
• Priority clinic appointment scheduling and surgical admission coordination with Dr. Ning Liao's dedicated surgical team at GDPH;
• Personalized oncoplastic planning consultations, second opinions on breast conservation feasibility, and full-course bilingual medical concierge accompaniment.